Feasibility and potential benefits of adjuvant chemotherapy with S-1 in patients with curative resected advanced biliary tract cancer: A multicenter trial.

被引:0
|
作者
Toyoki, Yoshikazu
Ishido, Keinosuke
Kudo, Daisuke
Kimura, Norihisa
Wakiya, Taiichi
Umehara, Yutaka
Tohyama, Shigeru
Endoh, Masaaki
Tateoka, Hiroshi
Ohishi, Susumu
Hakamada, Kenichi
机构
[1] Hirosaki Univ, Dept Surg Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan
[2] Aomori Prefectural Cent Hosp, Dept Surg, Aomori, Japan
[3] Hakodate Municipal Hosp, Dept Surg, Hakodate, Hokkaido, Japan
[4] Aomori Municipal Hosp, Dept Surg, Aomori, Japan
[5] Odate Municipal Gen Hosp, Dept Surg, Odate, Japan
[6] Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15179
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer
    Boku, N.
    Uesaka, K.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S77 - S77
  • [42] Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients
    Aoyama, Toru
    Katayama, Yusuke
    Murakawa, Masaaki
    Atsumi, Yosuke
    Yamaoku, Koichiro
    Kanazawa, Amane
    Higuchi, Akio
    Shiozawa, Manabu
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Yamamoto, Naoto
    Oshima, Takashi
    Yoshikawa, Takaki
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1115 - 1120
  • [43] Safety and feasibility of S-1 adjuvant chemotherapy for gastric cancer in elderly patients
    Toru Aoyama
    Takaki Yoshikawa
    Takafumi Watanabe
    Tsutomu Hayashi
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Gastric Cancer, 2012, 15 : 76 - 82
  • [44] Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy in Completely Resected Lung Cancer
    Kiribayashi, T.
    Hata, Y.
    Kishi, K.
    Nagashima, M.
    Nakayama, T.
    Ikeda, S.
    Kadokura, M.
    Ozeki, Y.
    Otsuka, H.
    Murakami, Y.
    Kusachi, S.
    Takagi, K.
    Iyoda, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1961 - S1962
  • [45] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [46] Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT)
    Ikeda, Masafumi
    Nakachi, Kohei
    Konishi, Masaru
    Nomura, Shogo
    Katayama, Hiroshi
    Kataoka, Tomoko
    Uesaka, Katsuhiko
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Wada, Hiroshi
    Shimada, Kazuaki
    Takahashi, Yu
    Nakagohri, Toshio
    Gotoh, Kunihito
    Kamata, Ken
    Shimizu, Yasuhiro
    Ueno, Makoto
    Ishii, Hiroshi
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [47] Feasibility Study of Adjuvant Chemotherapy with S-1 for Advanced Breast Cancer After Primary Systemic Chemotherapy
    Shigekawa, T.
    Osaki, A.
    Sano, H.
    Takeuchi, H.
    Misumi, M.
    Nakamiya, N.
    Fujiuchi, N.
    Saeki, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S171 - S171
  • [48] Examination of the feasibility of adjuvant chemotherapy with S-1 for gastric cancer
    Kawasaki, H
    Shibata, S
    Sasaki, M
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 191 - 194
  • [49] Phase II study of S-1 in patients with advanced biliary tract cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    BRITISH JOURNAL OF CANCER, 2004, 91 (10) : 1769 - 1774
  • [50] Phase II study of S-1 in patients with advanced biliary tract cancer
    H Ueno
    T Okusaka
    M Ikeda
    Y Takezako
    C Morizane
    British Journal of Cancer, 2004, 91 : 1769 - 1774